DrugCite
Search

NORDITROPIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Norditropin Adverse Events Reported to the FDA Over Time

How are Norditropin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Norditropin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Norditropin is flagged as the suspect drug causing the adverse event.

Most Common Norditropin Adverse Events Reported to the FDA

What are the most common Norditropin adverse events reported to the FDA?

Headache
112 (2.95%)
Condition Aggravated
87 (2.29%)
Convulsion
61 (1.61%)
Vomiting
54 (1.42%)
Nausea
44 (1.16%)
Papilloedema
42 (1.11%)
Pyrexia
40 (1.05%)
Sleep Apnoea Syndrome
38 (1%)
Scoliosis
34 (.9%)
Death
33 (.87%)
Osteochondrosis
33 (.87%)
Show More Show More
Asthenia
31 (.82%)
Disease Recurrence
31 (.82%)
Craniopharyngioma
30 (.79%)
Dehydration
30 (.79%)
Fatigue
29 (.76%)
Neoplasm Progression
29 (.76%)
Diarrhoea
27 (.71%)
Tonsillar Hypertrophy
26 (.69%)
Arthralgia
25 (.66%)
Blood Glucose Increased
25 (.66%)
Astrocytoma
24 (.63%)
Cardiac Failure Congestive
24 (.63%)
Pituitary Tumour Benign
24 (.63%)
Hyperglycaemia
22 (.58%)
Loss Of Consciousness
22 (.58%)
Decreased Appetite
21 (.55%)
Urinary Tract Infection
21 (.55%)
Brain Neoplasm
20 (.53%)
Epilepsy
20 (.53%)
Intracranial Pressure Increased
20 (.53%)
Malaise
20 (.53%)
Type 1 Diabetes Mellitus
18 (.47%)
Upper Respiratory Tract Infection
18 (.47%)
Back Pain
17 (.45%)
Pain In Extremity
17 (.45%)
Somnolence
17 (.45%)
Dyspnoea
16 (.42%)
Influenza
16 (.42%)
Myocardial Infarction
16 (.42%)
Pancreatitis
16 (.42%)
Cardiac Failure
15 (.4%)
Medulloblastoma
15 (.4%)
Migraine
15 (.4%)
Otitis Media
15 (.4%)
Chest Pain
14 (.37%)
Dizziness
14 (.37%)
Febrile Convulsion
14 (.37%)
Visual Acuity Reduced
14 (.37%)
Weight Decreased
14 (.37%)
Anxiety
13 (.34%)
Gait Disturbance
13 (.34%)
Myalgia
13 (.34%)
Oedema Peripheral
13 (.34%)
Osteonecrosis
13 (.34%)
Paraesthesia
13 (.34%)
Atrial Fibrillation
12 (.32%)
Bone Sarcoma
12 (.32%)
Meningioma
12 (.32%)
Sudden Death
12 (.32%)
Syncope
12 (.32%)
Benign Intracranial Hypertension
11 (.29%)
Diabetic Ketoacidosis
11 (.29%)
Epistaxis
11 (.29%)
Sepsis
11 (.29%)
Strabismus
11 (.29%)
Appendicitis
10 (.26%)
Asthma
10 (.26%)
Blood Creatine Phosphokinase Increa...
10 (.26%)
Cough
10 (.26%)
Cyst
10 (.26%)
Gastroenteritis
10 (.26%)
Gastrointestinal Haemorrhage
10 (.26%)
Hypersensitivity
10 (.26%)
Hyperthyroidism
10 (.26%)
Hypoglycaemic Seizure
10 (.26%)
Musculoskeletal Stiffness
10 (.26%)
Neck Pain
10 (.26%)
Pneumonia
10 (.26%)
Pruritus
10 (.26%)
Thyroid Cancer
10 (.26%)
Acth-producing Pituitary Tumour
9 (.24%)
Arthritis
9 (.24%)
Hair Follicle Tumour Benign
9 (.24%)
Hypertension
9 (.24%)
Hypertrophic Cardiomyopathy
9 (.24%)
Hypotension
9 (.24%)
Incorrect Dose Administered
9 (.24%)
Influenza Like Illness
9 (.24%)
Joint Dislocation
9 (.24%)
Neoplasm Recurrence
9 (.24%)
Pain
9 (.24%)
Platelet Count Decreased
9 (.24%)
Protein-losing Gastroenteropathy
9 (.24%)
Renal Failure
9 (.24%)
Respiratory Distress
9 (.24%)
Tenosynovitis Stenosans
9 (.24%)
Thrombocytopenia
9 (.24%)
Blood Pressure Increased
8 (.21%)
Breast Cancer
8 (.21%)
Enchondroma
8 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Norditropin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Norditropin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Norditropin

What are the most common Norditropin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Norditropin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Norditropin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Norditropin According to Those Reporting Adverse Events

Why are people taking Norditropin, according to those reporting adverse events to the FDA?

Growth Hormone Deficiency
675
Product Used For Unknown Indication
137
Body Height Below Normal
97
Drug Use For Unknown Indication
95
Hypopituitarism
92
Small For Dates Baby
81
Show More Show More
Haemodialysis
77
Turners Syndrome
49
Growth Retardation
35
Dwarfism
24
Ill-defined Disorder
22
Prader-willi Syndrome
19
Chondrodystrophy
19
Renal Failure Chronic
15
Off Label Use
13
Foetal Growth Retardation
12
Noonan Syndrome
10
Silver-russell Syndrome
9
Foetal Growth Restriction
8
Bone Density Decreased
6
Fatigue
5
Blood Growth Hormone Decreased
5
Postpartum Hypopituitarism
5
Hypochondroplasia
3
Fibromyalgia
3
Gonadal Dysgenesis
3
Hypoglycaemic Seizure
3
Failure To Thrive
3
Hypothalamo-pituitary Disorder
3
Short-bowel Syndrome
2
Hepatitis C
2
Lymphocytic Hypophysitis
2
Insulin-like Growth Factor Decrease...
2
Multiple Epiphyseal Dysplasia
2
Asthenia
2
Langerhans Cell Granulomatosis
2
Hypopituitarism Foetal
2
Blood Growth Hormone
2
Intentional Drug Misuse
2
Weight Increased
2
Pterygium
1
Hyperpituitarism
1
Brain Neoplasm
1
Surgery
1
Decreased Activity
1
Hormone Level Abnormal
1
Prophylaxis
1
Deficiency Anaemia
1
Post Procedural Complication
1
Lethargy
1
Depression
1

Drug Labels

LabelLabelerEffective
NorditropinPhysicians Total Care, Inc.02-MAR-10
NorditropinNovo Nordisk25-MAY-11

Norditropin Case Reports

What Norditropin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Norditropin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Norditropin.